drugset / Trial / NCT00615251

A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro Fertilization

NCT00615251

Phase 3 Completed 1297 enrolled Duramed Research
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a multi-center study to evaluate the effects of DR-2011 compared to a progesterone gel in women undergoing in vitro fertilization with fresh eggs. The overall study duration will be approximately 12 months and will involve ovarian suppression/stimulation protocols as well as egg retrieval.

Timeline

Start
2008-02
Primary completion
2009-08
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Progesterone Other / unclassified 8 % Other

Indications